Refine
Year of publication
Document Type
- Doctoral Thesis (3257)
- Article (1886)
- Book (23)
- Conference Proceeding (17)
- Course Material (5)
- Final Thesis (5)
- Report (5)
- Part of a Book (1)
- Habilitation (1)
Language
- English (2642)
- German (2554)
- Multiple languages (4)
Is part of the Bibliography
- no (5200)
Keywords
- - (1260)
- Sepsis (83)
- Staphylococcus aureus (59)
- Plasma (44)
- Diabetes mellitus (37)
- Epidemiologie (37)
- SHIP (34)
- Proteomanalyse (33)
- Depression (31)
- Prävention (30)
Institute
- Institut für Chemie und Biochemie (279)
- Institut für Physik (268)
- Kliniken und Polikliniken für Innere Medizin (263)
- Institut für Pharmazie (215)
- Abteilung für Mikrobiologie und Molekularbiologie (206)
- Institut für Community Medicine (198)
- Institut für Hygiene und Umweltmedizin (151)
- Institut für Botanik und Landschaftsökologie & Botanischer Garten (147)
- Zoologisches Institut und Museum (147)
- Institut für Psychologie (144)
- Institut für Geographie und Geologie (143)
- Klinik und Poliklinik für Neurologie (142)
- Institut für Diagnostische Radiologie (135)
- Institut für Pharmakologie (133)
- Klinik für Anästhesiologie und Intensivmedizin (130)
- Klinik für Psychiatrie und Psychotherapie (112)
- Poliklinik für Kieferorthopädie, Präventive Zahnmedizin und Kinderzahnheilkunde (108)
- Institut für Anatomie und Zellbiologie (103)
- Klinik und Poliklinik für Frauenheilkunde u. Geburtshilfe (100)
- Klinik und Poliklinik für Orthopädie und Orthopädische Chirurgie (98)
- Klinik und Poliklinik für Kinder- und Jugendmedizin (94)
- Poliklinik für Zahnerhaltung, Parodontologie und Endodontologie (94)
- Institut für Mathematik und Informatik (86)
- Institut für Mikrobiologie - Abteilung für Genetik & Biochemie (85)
- Klinik und Poliklinik für Chirurgie Abt. für Viszeral-, Thorax- und Gefäßchirurgie (84)
- Klinik und Poliklinik für Chirurgie Abt. für Unfall- und Wiederherstellungschirurgie (77)
- Institut für Klinische Chemie und Laboratoriumsmedizin (76)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (75)
- Klinik und Poliklinik für Augenheilkunde (71)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (67)
- Institut für Med. Biochemie u. Molekularbiologie (65)
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (MNF) (64)
- Wirtschaftswissenschaften (60)
- Friedrich-Loeffler-Institut für Medizinische Mikrobiologie (57)
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (UMG) (55)
- Institut für Medizinische Psychologie (54)
- Klinik und Poliklinik für Hals-, Nasen-, Ohrenkrankheiten (50)
- Klinik und Poliklinik für Innere Medizin Abt. Gastroenterologie, Endokrinologie und Ernährungsmedizin (49)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Transfusionsmedizin (48)
- Klinik und Poliklinik für Urologie (48)
- Poliklinik für zahnärztliche Prothetik und Werkstoffkunde (48)
- Klinik und Poliklinik für Neurochirurgie (44)
- Institut für Pathologie (41)
- Klinik und Poliklinik für Hautkrankheiten (35)
- Universitätsmedizin (35)
- Institut für Epidemiologie u. Sozialmedizin (34)
- Institut für Physiologie (33)
- Institut für Erziehungswissenschaft (31)
- Rechtswissenschaften (25)
- Institut für Pathophysiologie (24)
- Institut für Politik- und Kommunikationswissenschaft (23)
- Institut für Rechtsmedizin (21)
- Institut für Biometrie und Medizinische Informatik (20)
- Institut für Humangenetik (20)
- Zentrum für Zahn-, Mund- und Kieferheilkunde (20)
- Historisches Institut (17)
- Institut für Baltistik (17)
- Klinik und Poliklinik für Kinderchirurgie (17)
- Institut für Philosophie (16)
- Klinik und Poliklinik für Innere Medizin Abt. Nephrologie, Hochdruckkrankheiten und Dialyse (16)
- Institut für Anglistik/Amerikanistik (15)
- Institut für Deutsche Philologie (14)
- Caspar-David-Friedrich-Institut (13)
- Institut für Ethik und Geschichte der Medizin (13)
- Institut für Fennistik und Skandinavistik (13)
- Klinik und Poliklinik für Chirurgie (13)
- Mathematisch-Naturwissenschaftliche Fakultät (12)
- Klinik für Herz-, Thorax- und Gefäßchirurgie - Klinikum Karlsburg (11)
- Institut für Slawistik (9)
- Institut für Geologische Wissenschaften (8)
- Institut für Geschichte der Medizin (bis 2014) (8)
- Philosophische Fakultät (7)
- Rechts- und Staatswissenschaftliche Fakultät (7)
- Theologie (6)
- Klinik und Poliklinik für Nuklearmedizin (5)
- Klinik und Poliklinik für Strahlentherapie (2)
- Romanistik am Institut für Fremdsprachliche Philologien (2)
- Institut für Altertumswissenschaften (1)
- Theologische Fakultät (1)
Publisher
- MDPI (555)
- Frontiers Media S.A. (345)
- Wiley (164)
- S. Karger AG (145)
- Springer Nature (132)
- IOP Publishing (66)
- BioMed Central (BMC) (59)
- De Gruyter (48)
- SAGE Publications (38)
- Nature Publishing Group (34)
Riociguat is one of several approved therapies available for patients with pulmonary arterial hypertension (PAH). Treatment should be initiated and monitored at an expert center by a physician experienced in treating PAH, and the dose adjusted in the absence of signs and symptoms of hypotension. In certain populations, including patients with hepatic or renal impairment, the elderly, and smokers, riociguat exposure may differ, and dose adjustments should therefore be made with caution according to the established scheme. Common adverse events are often easily managed, particularly if they are discussed before starting therapy. Combination therapy with riociguat and other PAH-targeted agents is feasible and generally well tolerated, although the coadministration of phosphodiesterase type 5 inhibitors (PDE5i) and riociguat is contraindicated. An open-label, randomized study is currently ongoing to assess whether patients who do not achieve treatment goals while receiving PDE5i may benefit from switching to riociguat. In this review, we provide a clinical view on the practical management of patients with PAH receiving riociguat, with a focus on the opinions and personal experience of the authors.
The reviews of this paper are available via the supplemental material section.
The giant protein titin performs structure-preserving functions in the sarcomere and is important for the passive stiffness (Fpassive) of cardiomyocytes. Protein kinase D (PKD) enzymes play crucial roles in regulating myocardial contraction, hypertrophy, and remodeling. PKD phosphorylates myofilament proteins, but it is not known whether the giant protein titin is also a PKD substrate. Here, we aimed to determine whether PKD phosphorylates titin and thereby modulates cardiomyocyte Fpassive in normal and failing myocardium. The phosphorylation of titin was assessed in cardiomyocyte-specific PKD knock-out mice (cKO) and human hearts using immunoblotting with a phosphoserine/threonine and a phosphosite-specific titin antibody. PKD-dependent site-specific titin phosphorylation in vivo was quantified by mass spectrometry using stable isotope labeling by amino acids in cell culture (SILAC) of SILAC-labeled mouse heart protein lysates that were mixed with lysates isolated from hearts of either wild-type control (WT) or cKO mice. Fpassive of single permeabilized cardiomyocytes was recorded before and after PKD and HSP27 administration. All-titin phosphorylation was reduced in cKO compared to WT hearts. Multiple conserved PKD-dependent phosphosites were identified within the Z-disk, A-band and M-band regions of titin by quantitative mass spectrometry, and many PKD-dependent phosphosites detected in the elastic titin I-band region were significantly decreased in cKO. Analysis of titin site-specific phosphorylation showed unaltered or upregulated phosphorylation in cKO compared to matched WT hearts. Fpassive was elevated in cKO compared to WT cardiomyocytes and PKD administration lowered Fpassive of WT and cKO cardiomyocytes. Cardiomyocytes from hypertrophic cardiomyopathy (HCM) patients showed higher Fpassive compared to control hearts and significantly lower Fpassive after PKD treatment. In addition, we found higher phosphorylation at CaMKII-dependent titin sites in HCM compared to control hearts. Expression and phosphorylation of HSP27, a substrate of PKD, were elevated in HCM hearts, which was associated with increased PKD expression and phosphorylation. The relocalization of HSP27 in HCM away from the sarcomeric Z-disk and I-band suggested that HSP27 failed to exert its protective action on titin extensibility. This protection could, however, be restored by administration of HSP27, which significantly reduced Fpassive in HCM cardiomyocytes. These findings establish a previously unknown role for PKDin regulating diastolic passive properties of healthy and diseased hearts.
Interleukin-33 (IL-33) is a mucosal alarmin belonging to the IL-1 cytokine family and is now recognized to have a key role in innate and adaptive immunity, contributing to tissue homeostasis and response to environmental stresses. In addition, IL-33 has also been shown to work as a positive regulator that initiates and maintains a Th2 immune response. In the context of pregnancy, it has been recently demonstrated that upon certain stress conditions, such as an infection induced inflammation, IL-33 is released from the uterine mucosa and triggers decidual B cells to produce anti-inflammatory molecules, which in turn restore immune homeostasis and prevents the development of preterm birth. In this study we therefore performed a detailed characterization of IL-33 receptor (Il1rl1 or ST2) expression in B cells during normal pregnancy, as well as in a mouse model of preterm birth. We observed that splenic B cells significantly up-regulate the expression of Il1rl1 during pregnancy and identified the B1 B cell population as the main ST2-expressing B cell subset. A further kinetic analysis showed that percentages of ST2-expressing B1 B cells are significantly augmented on days 12 and 14 of pregnancy, both in the spleen and peritoneal cavity of pregnant mice, and then drop toward the end of pregnancy to the levels observed in non-pregnant animals. Furthermore, using a mouse model of LPS-induced preterm birth, we demonstrated that not only are the percentages of ST2-expressing B1 B cells significantly enlarged in the spleen during the acute phase of preterm birth, but decidual B cells also significantly up-regulate ST2 expression as compared to term-pregnant mice. Overall, our results suggest a functional role of ST2 expression in B cells during pregnancy and reinforce the importance of the IL-33/ST2 axis in B cells as a critical mechanism to control inflammation-induced preterm birth.
Age-related deterioration in white and gray matter is linked to cognitive deficits. Reduced microstructure of the fornix, the major efferent pathway of the hippocampus, and volume of the dentate gyrus (DG), may cause age-associated memory decline. However, the linkage between these anatomical determinants and memory retrieval in healthy aging are poorly understood. In 30 older adults, we acquired diffusion tensor and T1-weighted images for individual deterministic tractography and volume estimation. A memory task, administered outside of the scanner to assess retrieval of learned associations, required discrimination of previously acquired picture-word pairs. The results showed that fornix fractional anisotropy (FA) and left DG volumes were related to successful retrieval. These brain-behavior associations were observed for correct rejections, but not hits, indicating specificity of memory network functioning for detecting false associations. Mediation analyses showed that left DG volume mediated the effect of fornix FA on memory (48%), but not vice versa. These findings suggest that reduced microstructure induces volume loss and thus negatively affects retrieval of learned associations, complementing evidence of a pivotal role of the fornix in healthy aging. Our study offers a neurobehavioral model to explain variability in memory retrieval in older adults, an important prerequisite for the development of interventions to counteract cognitive decline.